4.7 Review

A systematic review and meta-analysis of the incidence rate of Takayasu arteritis

Journal

RHEUMATOLOGY
Volume 60, Issue 11, Pages 4982-4990

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keab406

Keywords

Takayasu arteritis; vasculitis; epidemiology; meta-analysis

Categories

Funding

  1. Vasculitis UK
  2. Vifor pharma

Ask authors/readers for more resources

Takayasu arteritis (TAK) is a rare autoimmune rheumatic disease that mainly affects individuals between the ages of 20 and 30. The incidence rate varies significantly among different populations, with higher rates observed in women. Future research should focus on specific populations to better identify genetic and environmental risk factors.
Objectives. Takayasu arteritis (TAK) is a rare autoimmune rheumatic disease causing large-vessel vasculitis. Onset is typically between the ages of 20 and 30 years. It is associated with substantial morbidity and mortality, notably due to its effects on the cardiovascular system. It has a poorly understood global epidemiology. Our objective was to systematically review the available evidence in order to calculate the incidence rate of TAK. Methods. Three databases (MEDLINE, PubMed and Embase) were searched in November 2019 and the results were screened by two reviewers. A random effects meta-analysis was then conducted in R to calculate the overall incidence rate. Heterogeneity was assessed using I-2. The quality of the studies was assessed using an adapted Newcastle-Ottawa scale. Further subgroup analyses were performed by quality, sex, research setting and geographical location. Publication bias was assessed using a Begg's funnel plot. Results. The incidence rate for TAK was 1.11 per million person-years (95% CI 0.70-1.76). The heterogeneity in the data was extremely high in all analyses, which suggests that there was considerable variation in incidence rates across the different populations studied. TAK was found to be more common in women (incidence rate 2.01 per million person-years, 95% CI 1.39-2.90). Conclusions. TAK is an extremely rare disease. It affects women more commonly than men. There is considerable variation in the incidence rate between populations. We suggest that future research should focus on discrete populations in order to better identify genetic and environmental risk factors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available